Glucotrack has announced the receipt of St Vincent’s Hospital Melbourne Human Research Ethics Committee’s (HREC) approval for ...

For those with insulin resistance, managing blood sugars is key. While traditional glucose meters require finger pricks, ...

Long-term clinical evaluation represents key advancement following successful first-in-human studyRUTHERFORD, N.J., May 13, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or ...

Roche will invest $550 million in Indianapolis for a new manufacturing facility for glucose monitoring devices, adding several hundred jobs.

Glucotrack's CBGM is a long-term implantable system with no wearable component, designed for up to three years of continuous, accurate blood glucose monitoring, offering a more convenient and less ...

Abbott is already a big player in the wearable glucose-monitoring sector, and has started working on a new device that will measure both glucose and ketones, potentially serving as a warning ...

The Glucotrack Continuous Blood Glucose Monitor is an Investigational Device ... levels with a sensor longevity of 3 years, no on-body wearable component and with minimal calibration.

Max Kopp, founder & CEO of VitaSense, featured at Philly Inno's 2025 Inno Under 25 awards ceremony. The framed Philadelphia Business Journa ...